Some observational reports suggest changes in menstrual cycles whilst taking GLP-1 receptor agonists, though there is limited evidence establishing these medications as direct causes of cycle disruption beyond the effects of weight loss itself
Every batch of Retatrutide undergoes independent HPLC purity testing and mass spectrometry identity verification before release, with Certificates of Analysis available through our Lab Results page
Emily Cooper, Mark Wright, and Andrea Taylor answer listener questions covering pregnancy planning on GLP-1s, unmasked thyroid problems, injection site reactions, mechanical eating after bariatric surgery, why diets cause fat regain at a cellular level, and discussing with your doctor whether you should (or shouldn't) increase your medication dose
Improving the pressing extraction of polyphenols of orange peel by pulsed electric fields
Hair loss is reported across the GLP-1 class (around 3% on injectable Wegovy, 5 to 6% on injectable Mounjaro) and is usually a temporary response to rapid weight loss rather than a direct effect of the drug
